HER2+ Metastatic Breast Cancer
1 clinical trials · Condition
◉ Watch HER2+ Metastatic Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Asciminib in HER2+ Breast Cancer Brain Metastases (NCT07136428) | Duke University | 2026-07-07 |
Track HER2+ Metastatic Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.